421 related articles for article (PubMed ID: 17420349)
1. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lewis P; Stefanovic N; Pete J; Calkin AC; Giunti S; Thallas-Bonke V; Jandeleit-Dahm KA; Allen TJ; Kola I; Cooper ME; de Haan JB
Circulation; 2007 Apr; 115(16):2178-87. PubMed ID: 17420349
[TBL] [Abstract][Full Text] [Related]
2. Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.
Chew P; Yuen DY; Koh P; Stefanovic N; Febbraio MA; Kola I; Cooper ME; de Haan JB
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):823-30. PubMed ID: 19325139
[TBL] [Abstract][Full Text] [Related]
3. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
[TBL] [Abstract][Full Text] [Related]
4. Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice.
Yi X; Xu L; Hiller S; Kim HS; Maeda N
Atherosclerosis; 2012 Jul; 223(1):137-43. PubMed ID: 22658261
[TBL] [Abstract][Full Text] [Related]
5. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.
Rasmiena AA; Barlow CK; Stefanovic N; Huynh K; Tan R; Sharma A; Tull D; de Haan JB; Meikle PJ
Atherosclerosis; 2015 Dec; 243(2):598-608. PubMed ID: 26545014
[TBL] [Abstract][Full Text] [Related]
6. Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse.
Chew P; Yuen DY; Stefanovic N; Pete J; Coughlan MT; Jandeleit-Dahm KA; Thomas MC; Rosenfeldt F; Cooper ME; de Haan JB
Diabetes; 2010 Dec; 59(12):3198-207. PubMed ID: 20823099
[TBL] [Abstract][Full Text] [Related]
7. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
Candido R; Jandeleit-Dahm KA; Cao Z; Nesteroff SP; Burns WC; Twigg SM; Dilley RJ; Cooper ME; Allen TJ
Circulation; 2002 Jul; 106(2):246-53. PubMed ID: 12105166
[TBL] [Abstract][Full Text] [Related]
8. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
[TBL] [Abstract][Full Text] [Related]
9. Imatinib attenuates diabetes-associated atherosclerosis.
Lassila M; Allen TJ; Cao Z; Thallas V; Jandeleit-Dahm KA; Candido R; Cooper ME
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):935-42. PubMed ID: 14988091
[TBL] [Abstract][Full Text] [Related]
10. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice.
Park JG; Yoo JY; Jeong SJ; Choi JH; Lee MR; Lee MN; Hwa Lee J; Kim HC; Jo H; Yu DY; Kang SW; Rhee SG; Lee MH; Oh GT
Circ Res; 2011 Sep; 109(7):739-49. PubMed ID: 21835911
[TBL] [Abstract][Full Text] [Related]
11. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
[TBL] [Abstract][Full Text] [Related]
12. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.
Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG
Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743
[TBL] [Abstract][Full Text] [Related]
13. Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice.
Douglas G; Bendall JK; Crabtree MJ; Tatham AL; Carter EE; Hale AB; Channon KM
Cardiovasc Res; 2012 Apr; 94(1):20-9. PubMed ID: 22287576
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.
Judkins CP; Diep H; Broughton BR; Mast AE; Hooker EU; Miller AA; Selemidis S; Dusting GJ; Sobey CG; Drummond GR
Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H24-32. PubMed ID: 19837950
[TBL] [Abstract][Full Text] [Related]
15. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
Torzewski M; Ochsenhirt V; Kleschyov AL; Oelze M; Daiber A; Li H; Rossmann H; Tsimikas S; Reifenberg K; Cheng F; Lehr HA; Blankenberg S; Förstermann U; Münzel T; Lackner KJ
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):850-7. PubMed ID: 17255533
[TBL] [Abstract][Full Text] [Related]
18. Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice.
Nguyen TK; Paone S; Baxter AA; Mayfosh AJ; Phan TK; Chan E; Peter K; Poon IKH; Thomas SR; Hulett MD
Atherosclerosis; 2024 May; 392():117519. PubMed ID: 38581737
[TBL] [Abstract][Full Text] [Related]
19. Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet.
de Haan JB; Witting PK; Stefanovic N; Pete J; Daskalakis M; Kola I; Stocker R; Smolich JJ
J Lipid Res; 2006 Jun; 47(6):1157-67. PubMed ID: 16508038
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.
Kislinger T; Tanji N; Wendt T; Qu W; Lu Y; Ferran LJ; Taguchi A; Olson K; Bucciarelli L; Goova M; Hofmann MA; Cataldegirmen G; D'Agati V; Pischetsrieder M; Stern DM; Schmidt AM
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):905-10. PubMed ID: 11397695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
